Ok it appears to be a rebate, but we seem to getting off track here. What is significant about what is happening is that AusIndustry consider this technology
"Technically Advanced Overseas Drug Development" and so do the FDA which granted the technology "Qualified
Infectious Disease Product (QIDP) status" the financial metrics are of limited concern ATM as most investors are not expecting the company to pay dividends in the immediate future.
Ok it appears to be a rebate, but we seem to getting off track...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $118.1M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 46.5¢ | 46.5¢ | $2.131K | 4.582K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1263 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.5¢ | 11173 | 5 |
View Market Depth
| Last trade - 12.38pm 04/12/2024 (20 minute delay) ? |
| RCE (ASX) Chart |
